SGHT — Sight Sciences, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1531177 ·
Last close
$8.93
Market Cap
$491.94M
52W High
$9.24
52W Low
$3.19
ADV30
219,197
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 23,388,000 | 21,374,000 | -3,888,000 | -4,446,000 | 104,872,000 | 79,753,000 | 51,978,000 |
| Mar 2026 | 19,698,000 | 16,978,000 | -12,413,000 | -12,980,000 | 109,702,000 | 84,962,000 | 55,799,000 |
| Dec 2025 | 20,385,000 | 17,788,000 | -3,669,000 | -4,162,000 | 115,300,000 | 91,965,000 | 51,358,000 |
| Sep 2025 | 19,906,000 | 17,197,000 | -7,905,000 | -8,169,000 | 116,256,000 | 92,373,000 | 51,966,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-23,238,000
Investing CF
$-93,000
Financing CF
$1,852,000
CapEx
$-386,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.56
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-402,149,000
Inventory
$5,695,000
Receivables
$11,386,000
ST Investments
—
EBIT TTM
$-24,636,000
Pretax Income TTM
$-29,789,000
Interest Exp TTM
$5,153,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$83,377,000
EBITDA
$-19,264,000
Free Cash Flow
$-8,611,250
Enterprise Value
$410,637,248
Total Cash
$79,753,000
Total Debt
$41,974,000
Shares Out
55,087,990
Trailing EPS
$-0.55
Book Value
$0.97
ROE
-48.4%
ROA
-10.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 77,363,000 | -37,099,000 | -38,426,000 | 115,300,000 | 51,358,000 | 63,942,000 | -29,694,000 |
| Dec 2024 | 79,866,000 | -50,532,000 | -51,507,000 | 142,839,000 | 55,316,000 | 87,523,000 | -22,351,000 |
| Dec 2023 | 81,056,000 | -57,274,000 | -55,547,000 | 166,651,000 | 46,436,000 | 120,215,000 | -47,184,000 |
| Dec 2022 | 71,331,000 | -83,954,000 | -86,242,000 | 213,073,000 | 52,997,000 | 160,076,000 | -75,965,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.43
Max Pain — expiry 2026-11-20 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $9.27 · call volume: 53 · put volume: 1Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NPCE | NeuroPace Inc | $482.60M | $14.06 | — |
| TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $514.89M | $22.73 | — |
| CERS | CERUS CORP | $528.00M | $2.62 | — |
| CLPT | ClearPoint Neuro, Inc. | $452.38M | $14.83 | — |
| BWAY | Brainsway Ltd. | $535.17M | $13.31 | — |
News headlines (Yahoo Finance, 1h cache)
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15
2026-09-01 20:05 · Yahoo
TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease
2026-08-19 11:05 · Yahoo
Sight Sciences (SGHT) Q2 2026 Earnings Call Transcript
2026-08-12 23:29 · Yahoo
Sight Sciences Inc (SGHT) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and Raised ...
2026-08-06 05:08 · Yahoo
Sight Sciences Q2 Earnings Call Highlights
2026-08-06 05:03 · Yahoo
Sight Sciences (SGHT) Stock Sees Modest Fair Value Cut As Analysts Revisit Guidance
2026-08-06 02:12 · Yahoo
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates
2026-08-05 22:10 · Yahoo
Sight Sciences Reports Second Quarter 2026 Financial Results
2026-08-05 20:05 · Yahoo
Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026
2026-07-22 20:05 · Yahoo
Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
2026-05-06 23:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.